Efficacy

Explore a range of data available for Enstilar®

Psoriasis patient support

*Dovobet® ointment is not available in Ireland


LEO Pharma Product Licence Indications
Enstilar® is indicated for the topical treatment of psoriasis vulgaris in adults.1  Prescribing information can be found here
Dovobet® ointment is indicated for the topical treatment of stable plaque psoriasis vulgaris amenable to topical therapy in adults. Prescribing information can be found here
Dovobet® gel is indicated for scalp psoriasis in adults and the topical treatment of mild to moderate “non-scalp” plaque psoriasis vulgaris in adults.3.  Prescribing information can be found here

  1. Enstilar® Summary of Product Characteristics 2018.
  2. Dovobet® Ointment Summary of Product Characteristics 2018.
  3. Dovobet® Gel Summary of Product Characteristics 2018.
MAT-25292 August 2019

Keep in touch with LEO Pharma

Latest product information, consultation tools, hot topics in dermatology and congress updates.  Be the first to know with LEO Pharma. Sign up

MAT-29941 November 2019

Holler Box